Advancing precision medicine for ovarian granulosa cell tumours
This month, the ovarian cancer research program at the Hudson Institute of Medical Research, in a collaboration with Monash Health, was awarded $2.2 million from [...]
MPCCC research partnership with Monash BDI to improve future accuracy of precision medicine
A new MPCCC partnership with Monash University’s Biomedicine Discovery Institute (Monash BDI) will investigate whether innovative research technologies, including multi-omic and organoid profiling, can improve the [...]
Precision Oncology advanced by international landmark study
Cancer patients are likely to benefit from more targeted treatments following work that has increased the number of identifiable cancer genome signatures to 97. The [...]
National collaboration to increase local cancer patients’ access to affordable genetic testing
Cancer patients treated in Victoria will benefit from more affordable access to molecular tumour profiling, following a new collaboration between the Australian Genomic Cancer Medicine [...]
New next-generation sequencing machine to boost translational genomic research and enable more precise treatment and management of cancer
A next-generation sequencing instrument, the NovaSeq6000, will build genomic research capacity for MPCCC partners and increase the speed and affordability of comprehensive tumour genome profiling [...]
MPCCC project develops precision DNA test for cancer patients
A non-invasive blood test could help doctors to diagnose cancer and monitor patient responses to treatment, based on the outcomes of MPCCC research project, The [...]
MPCCC Precision Oncology Seminars illuminate ways to tackle rare and aggressive cancers
The MPCCC Precision Oncology Program welcomed two eminent speakers in August and September 2019 to present at Precision Oncology Seminars. These seminars brought together researchers [...]
MPCCC’s Molecular Tumour Boards and Precision Oncology Seminars drive innovation in personalised cancer treatment
Since its commencement in September 2018, the MPCCC Precision Oncology Program has established regular Molecular Tumour Board meetings that focus on three distinct tumour streams. [...]
Eminent Australian Prof David Thomas delivers MPCCC’s March Precision Oncology Seminar
Prof David Thomas, Director of the Kinghorn Cancer Centre, Founder of the Australian Cancer Genomics Medicine Programme, and arguably Australia’s leader in precision oncology, captivated [...]
MPCCC to Launch a Network of Precision Oncology Tumour Boards and Seminars
A network of tumour-specific MPCCC Precision Oncology Tumour Boards will be rolled out across MPCCC partner sites in early 2019 thanks to funding received from [...]